MARRA, ANTONIO

MARRA, ANTONIO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 93 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study 2026 Ligorio, FrancescaProvenzano, LeonardoFotia, GiuseppeCurigliano, GiuseppeGiuliano, MarioGenerali, DanieleMazzoli, GiacomoSposetti, CaterinaFaso, ValeriaBoldrini, LauraMarra, AntonioCriscitiello, CarmenPruneri, GiancarloMariani, LuigiVernieri, Claudio + Article (author) -
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer 2026 Boscolo Bielo L.Marra A.Ferraro E. + Article (author) -
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 2026 Mazzoli, GiacomoProvenzano, LeonardoCurigliano, GiuseppeGenerali, DanieleFotia, GiuseppeDe Monte, MatteoLigorio, FrancescaFaso, ValeriaSchianca, Ambra CarnevaleMarra, AntonioCriscitiello, CarmenPruneri, GiancarloVernieri, Claudio + Article (author) -
Tracking response to neoadjuvant systemic therapy through circulating tumor DNA analysis in breast cancer 2026 Marra A. + Article (author) -
ESMO basic requirements for AI-based biomarkers in oncology (EBAI) 2026 Marra A. + Article (author) -
Molecular tumor board in patients with metastatic breast cancer 2025 Boscolo Bielo, LucaGuerini Rocco, ElenaCrimini, EdoardoRepetto, MatteoZhan, YinxiuBattaiotto, ElenaKatrini, JalissaMarsicano, RenatoZagami, PaolaTrapani, DarioCriscitiello, CarmenFusco, NicolaMarra, AntonioCurigliano, Giuseppe + Article (author) -
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy 2025 Venetis, KonstantinosCursano, GiuliaGiachetti, Pier Paolo Maria BertonConcardi, AlbertoDe Camilli, ElisaD'Ercole, MariannaFrascarelli, ChiaraMarra, AntonioViale, GiuseppeCurigliano, GiuseppeGuerini Rocco, ElenaCriscitiello, CarmenFusco, Nicola + Article (author) -
Oral selective estrogen receptor degraders for breast cancer treatment: focus on pharmacological differences 2025 Zagami, PaolaCriscitiello, CarmenMarra, AntonioCurigliano, Giuseppe + Article (author) -
Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment 2025 Carlo PesciaPier Paolo Berton GiachettiPaola ZagamiAntonio MarraDario TrapaniNicola FuscoCarmen CriscitielloGiuseppe Curigliano + Article (author) -
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact 2025 Venetis, KonstantinosFrascarelli, ChiaraBielo, Luca BoscoloCursano, GiuliaConcardi, AlbertoNegrelli, MariachiaraD'Ercole, MariannaPorta, Francesca MariaZhan, YinxiuMarra, AntonioTrapani, DarioCriscitiello, CarmenCurigliano, GiuseppeGuerini-Rocco, ElenaFusco, Nicola + Article (author) -
Multimodal histopathologic models stratify hormone receptor-positive early breast cancer 2025 Marra, AntonioGuerini-Rocco, ElenaFusco, NicolaFrascarelli, ChiaraDellapasqua, SilviaZagami, PaolaCurigliano, Giuseppe + Article (author) -
Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical Insights 2025 Negrelli, MariachiaraFrascarelli, ChiaraMangione, ElisaDi Tonno, ClementinaPorta, Francesca MariaL'Imperio, VincenzoMarra, AntonioCurigliano, GiuseppeVenetis, KonstantinosGuerini-Rocco, ElenaFusco, Nicola + Article (author) -
Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer 2025 Cursano, GiuliaConcardi, AlbertoFrascarelli, ChiaraMangione, ElisaSantaguida, StefanoTosoni, DanielaPece, SalvatoreMarra, AntonioCriscitiello, CarmenCurigliano, GiuseppeViale, GiuseppeVenetis, KonstantinosRocco, Elena GueriniFusco, Nicola + Article (author) -
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer 2025 Zattarin, EmmaMarra, AntonioVernieri, ClaudioEtessami, JulianDe Monte, MatteoCuoghi Costantini, RiccardoSposetti, CaterinaCurigliano, Giuseppe + Article (author) -
Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI models 2025 Frascarelli, ChiaraVenetis, KonstantinosMarra, AntonioConcardi, AlbertoD'Ercole, MariannaMangione, ElisaNegrelli, MariachiaraPorta, Francesca MariaKeswani, SakshiCurigliano, GiuseppeGuerini-Rocco, ElenaFusco, Nicola Article (author) -
Advancing breast cancer therapy in the era of molecular diagnostics 2025 Marra, AntonioVingiani, AndreaCurigliano, GiuseppePruneri, Giancarlo + Article (author) -
Real-world safety and efficacy profiles of trastuzumab deruxtecan in patients with advanced breast cancer 2025 Antonarelli, GGandini, SPellizzari, GTrapani, DDellapasqua, SMarra, AZagami, PCurigliano, G + Article (author) -
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives 2025 Marra, AMorganti, SCurigliano, G + Article (author) -
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology 2025 Giugliano, FedericaGiordano, ElisaGilardi, LauraZagami, PaolaMarra, AntonioTrapani, DarioBerton Giachetti, Pier Paolo MariaMalagutti, BiancaCurigliano, GiuseppeCeci, FrancescoCriscitiello, Carmen + Article (author) -
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer 2025 Berton Giachetti, Pier Paolo MariaMarra, AntonioCorti, ChiaraBoldrini, LauraSposetti, CaterinaCarnevale Schianca, AmbraZagami, PaolaTrapani, DarioMalagutti, BiancaVernieri, ClaudioCurigliano, GiuseppeCriscitiello, Carmen + Article (author) -